Guevara-Saldaña LM, Ospina-Cantillo J, Cardona-Villa R

Idioma: Español
Referencias bibliográficas: 52
Paginas: 331-350
Archivo PDF: 690.77 Kb.

RESUMEN

la urticaria crónica espontánea es una enfermedad que produce gran compromiso en la calidad de vida del paciente y de la que aún se desconocen, en gran parte, los mecanismos fisiopatológicos asociados, ya que no son generalizables en todos los individuos. Existen factores intrínsecos y extrínsecos implicados en el desarrollo y persistencia de la enfermedad, los cuales pueden actuar de forma individual o coexistente. En esta revisión se proponen algunos cambios en la clasificación actual de la enfermedad, donde se incluye una subdivisión dentro de la urticaria crónica denominada urticaria crónica mixta, la cual hace referencia a los casos donde coexisten factores intrínsecos y extrínsecos para la aparición de la enfermedad en el mismo individuo. Algunos procesos infecciosos virales, bacterianos y parasitarios se han asociado en el desarrollo o severidad de los síntomas de la urticaria crónica en un subgrupo de pacientes, por lo tanto, son incluidos como factores extrínsecos del individuo dentro de las urticarias crónicas inducibles no físicas. Estas modificaciones son propuestas con el fin de optimizar el diagnóstico y manejo de los pacientes con urticaria crónica mixta.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Altman K, Chang C. Pathogenic intracellular and autoimmune mechanisms in urticaria and angioedema. Clin Rev Allergy Immunol 2013; 45: 47- 62.

2. Moolani Y, Lynde C, Sussman G. Advances in Understanding and Managing Chronic Urticaria. F1000Res. Vol. 5 (ed 2016/03/08); 2016: 177.

3. Saini SS. Chronic spontaneous urticaria: etiology and pathogenesis. Immunol Allergy Clin North Am 2014; 34: 33-52.

4. Magerl M, Altrichter S, Borzova E, Gimenez-Arnau A, Grattan CE, Lawlor F, et al. The definition, diagnostic testing, and management of chronic inducible urticarias - The EAACI/GA(2) LEN/EDF/ UNEV consensus recommendations 2016 update and revision. Allergy 2016; 71: 780-802.

5. Sánchez J, Amaya E, Acevedo A, Celis A, Caraballo D, Cardona R. Prevalence of Inducible Urticaria in Patients with Chronic Spontaneous Urticaria: Associated Risk Factors. J Aller Cl Imm-Pract 2017; 5: 464-470.

6. Gu H, Li L, Gu M, Zhang G. Association between Helicobacter pylori Infection and Chronic Urticaria: A Meta-Analysis. Gastroenterol Res Pract 2015; 2015: 486974.

7. Arik Yilmaz E, Karaatmaca B, Sackesen C, Sahiner UM, Cavkaytar O, Sekerel BE, et al. Parasitic Infections in Children with Chronic Spontaneous Urticaria. Int Arch Allergy Imm 2016; 171: 130- 135.

8. Jain S. Pathogenesis of Chronic Urticaria: An Overview. Dermatol Res Pract 2014; 2014: 10.

9. Ferrer M. Immunological events in chronic spontaneous urticaria. Clin Transl Allergy 2015; 5: 30.

10. Criado PR, Criado RFJ, Maruta CW, dos Reis VMS. Chronic urticaria in adults: state-of-the-art in the new millennium. An Bras Dermatol 2015; 90: 74-89.

11. Sabroe RA, Fiebiger E, Francis DM, Maurer D, Seed PT, Grattan CE, et al. Classification of anti- FcepsilonRI and anti-IgE autoantibodies in chronic idiopathic urticaria and correlation with di sease severity. J Allergy Clin Immunol 2002; 110: 492-499.

12. Boguniewicz M. The autoimmune nature of chronic urticaria. Allergy Asthma Proc 2008; 29: 433-438.

13. Konstantinou GN, Asero R, Ferrer M, Knol EF, Maurer M, Raap U, et al. EAACI taskforce position paper: evidence for autoimmune urticaria and proposal for defining diagnostic criteria. J Allergy Clin Immunol 2013; 68: 27-36.

14. Puccetti A, Bason C, Simeoni S, Millo E, Tinazzi E, Beri R, et al. In chronic idiopathic urticaria autoantibodies against Fc epsilonRII/CD23 induce histamine release via eosinophil activation. Clin Exp Allergy 2005; 35: 1599-1607.

15. Fine LM, Bernstein JA. Guideline of Chronic Urticaria Beyond. Allergy Asthma Immun 2016; 8: 396-403.

16. O’Donnell BF, O’Neill CM, Francis DM, Niimi N, Barr RM, Barlow RJ, et al. Human leucocyte antigen class II associations in chronic idiopathic urticaria. Br J Dermatol 1999; 140: 853-858.

17. Calamita Z, Bronhara Pela Calamita A. HLA in patients with chronic spontaneous urticaria who are positive for anti-thyroid antibodies. J Eur Acad Dermatol Venereol 2013; 27: 661-662.

18. Vena GA, Cassano N, Marzano AV, Asero R. The Role of Platelets in Chronic Urticaria. Int Arch Allergy Inmunol 2016; 169: 71-79.

19. Tedeschi A, Kolkhir P, Asero R, Pogorelov D, Olisova O, Kochergin N, et al. Chronic urticaria and coagulation: pathophysiological and clinical aspects. Allergy 2014; 69: 683-691.

20. Bossi F, Frossi B, Radillo O, Cugno M, Tedeschi A, Riboldi P, et al. Mast cells are critically involved in serum-mediated vascular leakage in chronic urticaria beyond high-affinity IgE receptor stimulation. Allergy 2011; 66: 1538-1545.

21. Eckman JA, Hamilton RG, Gober LM, Sterba PM, Saini SS. Basophil phenotypes in chronic idiopathic urticaria in relation to disease activity and autoantibodies. J Invest Dermatol 2008; 128: 1956-1963.

22. Gyimesi E, Sipka S, Danko K, Kiss E, Hidvegi B, Gal M, et al. Basophil CD63 expression assay on highly sensitized atopic donor leucocytes-a useful method in chronic autoimmune urticaria. Br J Dermatol 2004; 151: 388-396.

23. Tedeschi A, Asero R, Marzano AV, Lorini M, Fanoni D, Berti E, et al. Plasma levels and skineosinophil- expression of vascular endothelial growth factor in patients with chronic urticaria. Allergy 2009; 64: 1616-1622.

24. Hartmann G, Battiany J, Poeck H, Wagner M, Kerkmann M, Lubenow N, et al. Rational design of new CpG oligonucleotides that combine B cell activation with high IFN-alpha induction in plasmacytoid dendritic cells. Eur J Immunol 2003; 33: 1633-1641.

25. Asero R, Tedeschi A, Riboldi P, Cugno M. Plasma of patients with chronic urticaria shows signs of thrombin generation, and its intradermal injection causes wheal-and-flare reactions much more frequently than autologous serum. J Allergy Clin Immunol 2006; 117: 1113-1117.

26. Cugno M, Tedeschi A, Asero R, Meroni PL, Marzano AV. Skin autoimmunity and blood coagulation. Autoimmunity 2010; 43: 189-194.

27. Marzano AV, Tedeschi A, Berti E, Fanoni D, Crosti C, Cugno M. Activation of coagulation in bullous pemphigoid and other eosinophil-related inflammatory skin diseases. Clin Exp Immunol 2011; 165: 44-50.

28. Cugno M, Asero R, Tedeschi A, Lazzari R, Marzano AV. Inflammation and coagulation in urticaria and angioedema. Curr Vasc Pharmacol 2012; 10: 653-658.

29. Harris RH, Mitchell JH. Chronic urticaria due to giardia lamblia. Arch dermatology Syphilol 1949; 59: 587-589.

30. Casero RD, Mongi F, Sanchez A, Ramirez JD. Blastocystis and urticaria: Examination of subtypes and morphotypes in an unusual clinical manifestation. Acta Trop 2015; 148: 156-161.

31. Osada Y, Kanazawa T. Parasitic helminths: new weapons against immunological disorders. J Biomed Biotechnol 2010; 2010: 743758.

32. Kolkhir P, Balakirski G, Merk HF, Olisova O, Maurer M. Chronic spontaneous urticaria and internal parasites--a systematic review. Allergy 2016; 71: 308-322.

33. Zakzuk J. Inmunorregulación inducida por helmintos: una actualización. Iatreia 2016; 29: 182- 193.

34. Dilek AR, Dilek N, Saral Y, Ekşi S. The role of protozoa in the etiology of chronic urticaria. Dermatol Sin 2012; 30: 90-92.

35. Daschner A, Vega de la Osada F, Pascual CY. Allergy and parasites reevaluated: wide-scale induction of chronic urticaria by the ubiquitous fish-nematode Anisakis simplex in an endemic region. Allergol Immunopathol (Madr) 2005; 33: 31-37.

36. Lepczynska M, Chen WC, Dzika E. Mysterious chronic urticaria caused by Blastocystis spp.? Int J Dermatol 2016; 55: 259-266; quiz 263-254, 266.

37. Minciullo PL, Cascio A, Isola S, Gangemi S. Different clinical allergological features of Taenia solium infestation. Clin Mol Allergy 2016; 14: 18.

38. Cover TL, Blaser MJ. Helicobacter pylori y otras especies gástricas de Helicobacter. En: Bennett JE, Dolin R, Blaser MJ, eds. Mandell, Douglas y Bennett-Enfermedades infecciosas: Principios y práctica. Vol. 2. España: Elsevier; 2016: 2631- 2639.

39. Gurney S, Carvalho L, Gonzalez C, Galaviz E, Sonstein F. An Efficacious and Cost-Effective Pharmacologic Treatment for Helicobacter pylori. J Nurse Pract 2014; 10: 22-29.

40. Otero W, Trespalacios AA, Otero L, Vallejo MT, Torres Amaya M, Pardo R, et al. Guía de práctica clínica para el diagnóstico y tratamiento de la infección por Helicobacter pylori en adultos. Rev Col Gastroenterol 2015; 30: 17-33.

41. Shiotani A, Okada K, Yanaoka K, Itoh H, Nishioka S, Sakurane M, et al. Beneficial effect of Helicobacter pylori eradication in dermatologic diseases. Helicobacter 2001; 6: 60-65.

42. Supajatura V, Ushio H, Wada A, Yahiro K, Okumura K, Ogawa H, et al. Cutting edge: VacA, a vacuolating cytotoxin of Helicobacter pylori, directly activates mast cells for migration and production of proinflammatory cytokines. J Immunol 2002; 168: 2603-2607.

43. Tsai CC, Kuo TY, Hong ZW, Yeh YC, Shih KS, Du SY, et al. Helicobacter pylori neutrophil-activating protein induces release of histamine and interleukin- 6 through G protein-mediated MAPKs and PI3K/Akt pathways in HMC-1 cells. Virulence 2015; 6: 755-765.

44. Tan R-J, Sun H-Q, Zhang W, Yuan H-M, Li B, Yan H-T, et al. A 21-35 kDa Mixed Protein Component from Helicobacter pylori Activates Mast Cells Effectively in Chronic Spontaneous Urticaria. Helicobacter 2016; 21: 565-574.

45. Bakos N, Fekete B, Prohaszka Z, Fust G, Kalabay L. High prevalence of IgG and IgA antibodies to 19-kDa Helicobacter pylori-associated lipoprotein in chronic urticaria. Allergy 2003; 58: 663- 667.

46. Liutu M, Kalimo K, Uksila J, Savolainen J. Extraction of IgE-binding components of Helicobacter pylori by immunoblotting analysis in chronic urticaria patients. Int Arch Allergy Immunol 2001; 126: 213-217.

47. Vestergaard C, Toubi E, Maurer M, Triggiani M, Ballmer-Weber B, Marsland A, et al. Treatment of chronic spontaneous urticaria with an inadequate response to H1-antihistamines: an expert opinion. Eur J Dermatol 2017; 27: 10-19.

48. Greiwe J, Bernstein JA. Therapy of antihistamine- resistant chronic spontaneous urticaria. Expert Review of Clinical Immunology 2017; 13: 311-318.

49. Zuberbier T, Aberer W, Asero R, Bindslev-Jensen C, Brzoza Z, Canonica GW, et al. Methods report on the development of the 2013 revision and update of the EAACI/GA2 LEN/EDF/WAO guideline for the definition, classification, diagnosis, and management of urticaria. Allergy 2014; 69: e1- 29.

50. Kulthanan K, Tuchinda P, Chularojanamontri L, Chanyachailert P, Korkij W, Chunharas A, et al. Clinical practice guideline for diagnosis and management of urticaria. Asian Pac J Allergy 2016; 34: 190-200.

51. Powell RJ, Leech SC, Till S, Huber PA, Nasser SM, Clark AT. BSACI guideline for the management of chronic urticaria and angioedema. Clin Exp Allergy 2015; 45: 547-565.

52. Vestergaard C, Deleuran M. Chronic spontaneous urticaria: latest developments in aetiology, diagnosis and therapy. Ther Adv Chronic Dis 2015; 6: 304-313.